Tuesday, June 28, 2022
12:34 PM EST – Optimi Health : Announced that it has entered into a supply agreement with SABI Mind, a Calgary-based clinic group providing psychedelic-assisted therapies.
The Company has signed an agreement which will provide SABI Mind’s trained clinical staff with supplies of GMP psilocybin and 3,4-Methylenedioxymethamphetamine, pending the anticipated approval of its previously announced licensing amendment, for use with approved patients via Health Canada’s Special Access Program, clinical trials, and academic studies. Optimi Health (C.OPTI) shares were down one cent at 0.28.
Stocks in Play: Optimi Health , Tue, 28 Jun 2022 12:42:16 EST